Third Annual Health Law Year in P/Review
Couldn't make it in person? Check out the individual sessions in the videos linked above!
The Third Annual Health Law Year in P/Review symposium featured leading experts discussing major developments during 2014 and what to watch out for in 2015. The discussion at this day long event covered hot topics in such areas as health insurance, health care systems, public health, innovation, and other issues facing clinicians and patients.
For more on the topics discussed at the conference, check out Gregory Curfman (Harvard Health Publications of Harvard Medical School), Holly Fernandez Lynch (Petrie-Flom Center), I. Glenn Cohen (Petrie-Flom Center) on the Health Affairs Blog: "Last Year Was A Wild One For Health Law — What’s On The Docket For 2015?"
For a wrap-up of this year's P/Review and a discussion of what's to come at our Fourth Annual Health Law Year in P/Review in January 2016, check out Holly Fernandez Lynch, I. Glenn Cohen, and Gregory Curfman's wrap-up at the Health Affairs Blog, "Until Next Year".
Slide presentations by selected presenters are available upon request. Please contact firstname.lastname@example.org if you would like to request slides.
All panels concluded with time for audience Q&A.
7:45 - 8:15am, Registration
A continental breakfast will be provided.
8:15 - 8:20, Welcome Remarks
Gregory Curfman, Harvard Health Publications of Harvard Medical School
8:20 - 9:05am, Session 1: Public Health
The Legal and Public Health Response to Ebola - George Annas, Boston University
Read George Annas's dicussion of "What Ebola Teaches Us about Public Health in America" at the Health Affairs Blog.
Legal Measures to Stem Antibiotic Resistance - Kevin Outterson, Boston University
Read Kevin Outterson's discussion of "The Puzzle of Antibiotic Innovation" at the Health Affairs Blog.
9:05 - 9:50am, Session 2: Tobacco
Read Andrew Sussman's discussion of "What Happens When a Pharmacy Decides to Stop Selling Cigarettes?" at the Health Affairs Blog.
Regulating E-Cigarettes - Wendy Parmet, Northeastern University
Read Wendy Parmet's discussion "In Regulating E-Cigarettes, No Easy Fix for the FDA" at the Health Affairs Blog.
9:50 - 10:00am, Break
10:00 - 11:25am, Session 3: Issues Facing Clinicians
Payment Disclosure Requirements and Databases - Christopher T. Robertson, University of Arizona
Read Christopher Robertson's discussion of "Open Payments: Early Impact and the Next Wave of Reform," co-authored by Tony Caldwell, at the Health Affairs Blog.
Medical Child Abuse - Christine Mitchell, Harvard Medical School
Medicalization of Execution - I. Glenn Cohen, Harvard Law School/Petrie-Flom Center
Read I. Glenn Cohen's discussion of "Executions, Doctors, The U.S. Supreme Court, And The Breath Of Kings" at the Health Affairs Blog.
Brittany Maynard Effect: Aid in Dying - Charles “Buzzy” Baron, Boston College
Read Charles Baron's discussion of "Physician Aid In Dying: Whither Legalization After Brittany Maynard?" at the Health Affairs Blog.
11:25am - 12:10pm, Session 4: Innovation
Key Life Science IP Cases of 2014 - Claire Laporte, Foley Hoag
Read Claire Laporte's discussion, "Recent Judicial Rulemaking Leaves Life Science Patents Hanging In The Balance," at the Health Affairs Blog.
FDA Regulation of Lab-Developed Tests - Rachel Sachs, Harvard Law School/Petrie-Flom Center
Read Rachel Sachs' discussion, "The Complex Effects Of The FDA’s Proposal To Regulate Laboratory-Developed Tests," at the Health Affairs Blog.
12:10 - 12:30pm, Pick up Lunch
Lunch will be provided.
12:30 - 1:20pm, Hot Topics in Massachusetts Health Law
Jeffrey Sanchez, House Chairman for Joint Committee on Public Health, Massachusetts House of Representatives
1:20 - 1:30pm, Break
1:30 - 2:15pm, Session 5: Health Insurance
The ACA, Exchanges, and Subsidies: Key Cases - Abbe Gluck, Yale Law School
The ACA, Exchanges, and Subsidies: Policy and Implementation - Matthew J. B. Lawrence, Harvard Law School/Petrie-Flom Center
Read Matthew J. B. Lawrence's discussion of "Exploring The Significant State-To-State Variation In Marketplace Enrollment" at the Health Affairs Blog.
2:15 - 3:00pm, Session 6: Employer Involvement in Health Care
The Contraceptives Coverage Mandate and Accommodations - Holly Fernandez Lynch, Harvard Law School/Petrie-Flom Center
Read Holly Fernandez Lynch's related discussion, "What Does Indiana’s Religious Freedom Law Mean For Health Care?," at the Health Affairs Blog.
Employee Wellness Programs - Kristin Madison, Northeastern University
Read Kristin Madison's discussion of "The ACA, The ADA, And Wellness Program Incentives" at the Health Affairs Blog.
3:00 - 3:15pm, Break
3:15 - 4:40pm, Session 7: Health Care Systems
Antitrust and Hospital Mergers - Amitabh Chandra, Harvard Kennedy School
New Supreme Court Ruling on The Antitrust Liability of State Licensing Boards - Einer Elhauge, Harvard Law School
Learning Health Care Systems - Millie Solomon, Harvard Medical School/The Hastings Center
Read Millie Solomon's discussion on "How Institutional Review Boards Can Support Learning Health Systems While Providing Meaningful Oversight" at the Health Affairs Blog.
Problems at the VA - Ashish Jha, Harvard School of Public Health
4:40 - 4:55pm, Closing Remarks
Dean Martha Minow, Harvard Law School
4:55 - 5:00pm, Cosponsors Adjournment
Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the New England Journal of Medicine; co-sponsored by the Center for Bioethics at Harvard Medical School, the Hastings Center, and Health Affairs, with support from the Oswald DeN. Cammann Fund.
VIDEO: Session 1: Public Health
VIDEO: Session 2: Tobacco
VIDEO: Session 3: Issues Facing Clinicians
VIDEO: Session 4: Innovation
VIDEO: Hot Topics in Massachusetts Health Law
VIDEO: Session 5: Health Insurance
VIDEO: Session 6: Employer Involvement in Health Care
VIDEO: Session 7: Health Care Systems
abortion bioethics biotechnology conscience contraception criminal law end-of-life fda global health health care finance health care reform health law policy human subjects research innovation insurance intellectual property judicial opinions pharmaceuticals public health regulation veterans